Rhode Island Multistate Pharmacy Jurisprudence (MPJE) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the Rhode Island Multistate Pharmacy Jurisprudence Exam. Access multiple choice questions, hints, and detailed explanations. Prepare effectively for your exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which of the following information must be recorded in a bound record book for dispensing non-prescription opioids?

  1. Prescription number

  2. Name and address of purchaser

  3. Insurance provider

  4. Date of birth of the purchaser

The correct answer is: Name and address of purchaser

The requirement to record the name and address of the purchaser in a bound record book when dispensing non-prescription opioids is driven by regulatory mandates aimed at preventing misuse and tracking the distribution of these substances. This information is crucial for identifying individuals who are purchasing non-prescription opioids, allowing for better oversight and accountability. Recording the name and address helps create a reliable trail of who is acquiring these products, which is particularly important given the potential for abuse associated with opioids. This requirement supports broader public health goals by enabling authorities to monitor patterns of consumption and potentially identify cases of misuse or illegal distribution. The other information listed is not required for this specific documentation. For instance, while the prescription number pertains to prescription medications where a tracking system is more commonly in place, the insurance provider's details are often related to reimbursement processes rather than tracking purchases of non-prescription opioids. Similarly, the date of birth, although it might seem relevant for identification purposes, is not mandated as a part of the record-keeping for the sale of non-prescription opioids under current regulations in Rhode Island. Therefore, the focus on the purchaser’s name and address reflects the regulatory intent to rigorously monitor the sale of non-prescription opioids.